These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

481 related items for PubMed ID: 25648037

  • 61. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
    Druker BJ, Sawyers CL, Kantarjian H, Resta DJ, Reese SF, Ford JM, Capdeville R, Talpaz M.
    N Engl J Med; 2001 Apr 05; 344(14):1038-42. PubMed ID: 11287973
    [Abstract] [Full Text] [Related]

  • 62. Therapy-related acute myeloid leukemia after single-agent treatment with fludarabine for chronic lymphocytic leukemia.
    Lam CC, Ma ES, Kwong YL.
    Am J Hematol; 2005 Aug 05; 79(4):288-90. PubMed ID: 16044456
    [Abstract] [Full Text] [Related]

  • 63. Acute myeloid leukemia developing during imatinib mesylate therapy for chronic myeloid leukemia in the absence of new cytogenetic abnormalities.
    Pawarode A, Sait SN, Nganga A, Coignet LJ, Barcos M, Baer MR.
    Leuk Res; 2007 Nov 05; 31(11):1589-92. PubMed ID: 17391756
    [Abstract] [Full Text] [Related]

  • 64. Allogeneic stem cell transplantation for acute myeloid leukemia with del(7q) following untreated chronic lymphocytic leukemia.
    DeFilipp Z, Huynh DV, Fazal S, Sahovic E.
    Hematol Oncol Stem Cell Ther; 2012 Nov 05; 5(3):165-8. PubMed ID: 23095794
    [Abstract] [Full Text] [Related]

  • 65. [Efficacy of imatinib mesylate, a specific inhibitor of BCR/ABL tyrosine kinase, on chronic myeloid leukemia in blast phase].
    Zhang GC, Zheng D, Li QH, Li XH, Cai CC, Luo SK, Li J, Peng AH, Tong XZ, Tan EX, Hong WD.
    Ai Zheng; 2004 Dec 05; 23(12):1696-9. PubMed ID: 15601563
    [Abstract] [Full Text] [Related]

  • 66. Dasatinib in children and adolescents with relapsed or refractory leukemia: results of the CA180-018 phase I dose-escalation study of the Innovative Therapies for Children with Cancer Consortium.
    Zwaan CM, Rizzari C, Mechinaud F, Lancaster DL, Lehrnbecher T, van der Velden VH, Beverloo BB, den Boer ML, Pieters R, Reinhardt D, Dworzak M, Rosenberg J, Manos G, Agrawal S, Strauss L, Baruchel A, Kearns PR.
    J Clin Oncol; 2013 Jul 01; 31(19):2460-8. PubMed ID: 23715577
    [Abstract] [Full Text] [Related]

  • 67. The simultaneous occurrence of variant hairy cell leukemia and chronic-phase chronic myelogenous leukemia. A case report.
    Reeves JE, Robbins BA, Pankey LR, Elias AL, Anderson WF.
    Cancer; 1995 Apr 15; 75(8):2089-92. PubMed ID: 7697598
    [Abstract] [Full Text] [Related]

  • 68. Therapy-related refractory anemia with ringed sideroblasts in chronic lymphocytic leukemia. involvement of 3q21 region.
    Yağci M, Sucak GT, Oğur G, Haznedar R.
    Cancer Genet Cytogenet; 2001 Aug 15; 129(1):43-6. PubMed ID: 11520565
    [Abstract] [Full Text] [Related]

  • 69. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C, Loher F, Zang C, Ismair MG, Petrides PE.
    Clin Cancer Res; 1999 May 15; 5(5):1115-24. PubMed ID: 10353746
    [Abstract] [Full Text] [Related]

  • 70. Acute myeloid leukemia, inversion 16, occurring in a patient with chronic lymphocytic leukemia.
    Barresi GM, Albitar M, O'Brien SM.
    Leuk Lymphoma; 2000 Aug 15; 38(5-6):621-5. PubMed ID: 10953984
    [Abstract] [Full Text] [Related]

  • 71. p53 gene mutations with chromosome 17 abnormalities in chronic myelogenous leukemia blast crisis patients persist in long-term cell lines but may be acquired in acute myeloid leukemia cells in vitro.
    Sen S, Zhou H, Andersson BS, Cork A, Freireich EJ, Stass SA.
    Cancer Genet Cytogenet; 1995 Jul 01; 82(1):35-40. PubMed ID: 7627932
    [Abstract] [Full Text] [Related]

  • 72. B-lymphoid/myeloid stem cell origin in Ph-positive acute leukemia with myeloid markers.
    Akashi K, Taniguchi S, Nagafuji K, Harada M, Shibuya T, Hayashi S, Gondo H, Niho Y.
    Leuk Res; 1993 Jul 01; 17(7):549-55. PubMed ID: 8326735
    [Abstract] [Full Text] [Related]

  • 73. Expression of interferon regulatory factor 4 in chronic myeloid leukemia: correlation with response to interferon alfa therapy.
    Schmidt M, Hochhaus A, König-Merediz SA, Brendel C, Proba J, Hoppe GJ, Wittig B, Ehninger G, Hehlmann R, Neubauer A.
    J Clin Oncol; 2000 Oct 01; 18(19):3331-8. PubMed ID: 11013272
    [Abstract] [Full Text] [Related]

  • 74. U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval.
    Cohen MH, Johnson JR, Pazdur R.
    Clin Cancer Res; 2005 Jan 01; 11(1):12-9. PubMed ID: 15671523
    [Abstract] [Full Text] [Related]

  • 75. Hyperleukocytotic secondary acute myeloid leukemia (AML) with sole monosomy 7 as sequela of Philadelphia-chromosome positive chronic myeloid leukemia (CML).
    Hackanson B, Rückert A, Lübbert M.
    Eur J Haematol; 2009 Dec 01; 83(6):611-2. PubMed ID: 19682063
    [No Abstract] [Full Text] [Related]

  • 76. Treatment of chronic myelogenous leukemia in accelerated and blastic phases with daunorubicin, high-dose cytarabine, and granulocyte-macrophage colony-stimulating factor.
    Kantarjian HM, Talpaz M, Kontoyiannis D, Gutterman J, Keating MJ, Estey EH, O'Brien S, Rios MB, Beran M, Deisseroth A.
    J Clin Oncol; 1992 Mar 01; 10(3):398-405. PubMed ID: 1740679
    [Abstract] [Full Text] [Related]

  • 77. Expression of constitutively active nuclear-kappa B RelA transcription factor in blasts of acute myeloid leukemia.
    Bueso-Ramos CE, Rocha FC, Shishodia S, Medeiros LJ, Kantarjian HM, Vadhan-Raj S, Estrov Z, Smith TL, Nguyen MH, Aggarwal BB.
    Hum Pathol; 2004 Feb 01; 35(2):246-53. PubMed ID: 14991544
    [Abstract] [Full Text] [Related]

  • 78. Development of acute promyelocytic leukemia with isochromosome 17q after BCR/ABL positive chronic myeloid leukemia.
    Oren H, Düzovali O, Yüksel E, Sakizli M, Irken G.
    Cancer Genet Cytogenet; 1999 Mar 01; 109(2):141-3. PubMed ID: 10087949
    [Abstract] [Full Text] [Related]

  • 79. FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia.
    Neviani P, Santhanam R, Oaks JJ, Eiring AM, Notari M, Blaser BW, Liu S, Trotta R, Muthusamy N, Gambacorti-Passerini C, Druker BJ, Cortes J, Marcucci G, Chen CS, Verrills NM, Roy DC, Caligiuri MA, Bloomfield CD, Byrd JC, Perrotti D.
    J Clin Invest; 2007 Sep 01; 117(9):2408-21. PubMed ID: 17717597
    [Abstract] [Full Text] [Related]

  • 80. Chronic leukemia.
    Greenberg EM, Probst A.
    Crit Care Nurs Clin North Am; 2013 Dec 01; 25(4):459-70, vi. PubMed ID: 24267282
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.